Abstract
This research service provides a detailed analysis of the current state of the global stem cell therapeutics market, and future trends. It begins with a comparision of stem cell legislations and funding scenario between various countries. It also includes key market trends, industry challenges, market drivers, competitive structure, potential applications, and market opportunity analysis for key disease areas such as cancer, neurodenegerative disorders, cardiovascular diseases, diabetes and tissue engineering. Further, it contains competitive analysis, database of key research institutes, strategic recommendations to market participants and DSDs.
Table of Contents
1 EXECUTIVE SUMMARY
- Executive Summary
- Executive Summary
2 GLOSSARY OF TERMS
- Glossary of Terms
- Definitions
3 RESEARCH METHODOLOGY
- Research Methodology
- Methodology of Research for the World Stem Cell Therapeutics Market
4 INTRODUCTION
- Key Trends
- Stem Cell Legislations- United States Versus Europe
- Perspectives on Emerging Business Models
- Epigenetics and Stem Cell Therapy
- Cloning: Therapeutic Versus Reproductive
- Other Key Issues
5 WORLD-WIDE SCENARIO
- Region-wise Analysis of Legislations and Funding
- Introduction
- The United States of America
- Canada
- Europe
- Israel
- Asia Pacific
6 MARKET ENGINEERING RESEARCH
- The Overall Stem Cell Therapeutics Market
- Industry Challenges
- Market Drivers
- Competitive Structure
- Potential Applications of Stem Cell Therapy
- Cancers
- Market Overview
- Market Opportunity Analysis
- Cardiovascular Diseases
- Market Overview
- Market Opportunity Analysis
- Diabetes
- Market Overview
- Market Opportunity Analysis
- Neurodegenerative Disorders
- Market Overview
- Market Opportunity Analysis
- Tissue Engineering
- Market Overview
- Market Opportunity Analysis
7 COMPETITIVE ANALYSIS
- Analysis of Key Competitors
- Aastrom Biosciences
- Advanced Cell Technology Inc
- Amcyte Inc
- Artecel Inc
- Athersys Inc
- Axordia Therapeutics Inc
- Baxter Healthcare Corporation
- Bioheart Inc
- Brainstorm Cell Therapeutics
- Celgene Corp
- Cellartis AB
- CellGenix Technologie Transfer GmBH
- Cytomatrix LLC
- Cytori Therapeutics Inc
- ES Cell International
- Geron Corporation
- Ixion Biotechnology Inc
- Living Cell Technologies Inc
- MicroIslet Inc
- Morphogenesis Inc
- Neuronyx Inc
- Novocell Inc.
- Osiris Therapeutics Inc
- Regentec Ltd.
- Regenetech Inc
- Renamed Biologics
- Reneuron Group Plc
- SinoCells Biotechnologies Co.
- Stem Cells Inc
- Theravitae Inc
- Tristem Corporation
- Vesta Therapeutics
- Viacell Inc
8 MARKET ENGINEERING STRATEGIES
- Strategic Recommendations
- Recommendations to Market Participants
- Recommendations to Key Decision Makers
9 DATABASE OF KEY STEM CELL RESEARCH INSTITUTES
- Key Research Institutes By Country
- Australia
- Canada
- Israel
- Singapore
- Sweden
- United States of America
- United Kingdom
- Key Research Institutes by Disorder Segment
- Stem Cell Therapy for Cardiovascular Diseases
- Stem Cell Therapy for Type I Diabetes
- Stem Cell Therapy for Liver Diseases
- Stem Cell Therapy for Neurodegenerative Disorders
10 DECISION SUPPORT DATABASES
- Decision Support Tables
- Incidence of Breast Cancer
- Prevalence of Coronary Heart Disease
- Prevalence of Diabetes
- Incidence of Myocardial Infarction
- Prevalence of Parkinson' s Disease
- Incidence of Stroke
